TENOFOVIR DISOPROXIL FUMARATE TABLETS

TENOFOVIR DISOPROXIL FUMARATE TABLETS was reported 8648 times

TENOFOVIR DISOPROXIL FUMARATE TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CSF HIV VIRUS IDENTIFIED 14 0.6087
1 PERINATAL HBV INFECTION 9 0.5294
2 CSF VIRUS IDENTIFIED 30 0.4286
3 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 50 0.3876
4 HBV-DNA POLYMERASE INCREASED 5 0.3846
5 ULTRASOUND ANTENATAL SCREEN 34 0.3542
6 RETROPERITONEAL DISORDER 8 0.3478
7 CONGENITAL TUBERCULOSIS 4 0.3333
8 ANAL CHLAMYDIA INFECTION 4 0.3333
9 HYDRANENCEPHALY 7 0.2917
10 HIV VIRAEMIA 61 0.2905
11 PERITONEAL THICKENING 8 0.2857
12 HYDROMYELIA 7 0.2500
13 HIV PERIPHERAL NEUROPATHY 4 0.2353
14 VIRAL MUTATION IDENTIFIED 707 0.1918
15 ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 7 0.1892
16 VIROLOGIC FAILURE 744 0.1382
17 HIV ASSOCIATED NEPHROPATHY 7 0.1373
18 RENAL TUBULAR DYSFUNCTION 71 0.1257
19 HEPATITIS B E ANTIGEN POSITIVE 5 0.1190
20 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 39 0.1164
21 CSF HIV ESCAPE SYNDROME 16 0.1159
22 BIRTH MARK 24 0.1154
23 ACTH STIMULATION TEST ABNORMAL 4 0.1143
24 PERITONEAL CYST 6 0.1111
25 HEPATITIS D 9 0.1071
26 SCROTAL CYST 9 0.1059
27 AIDS ENCEPHALOPATHY 6 0.1034
28 CONGENITAL KNEE DISLOCATION 4 0.1000
29 HEREDITARY OPTIC ATROPHY 7 0.1000
30 CHRONIC HEPATITIS B 31 0.0978
31 CONGENITAL UMBILICAL HERNIA 34 0.0912
32 HYPOPHOSPHATAEMIC OSTEOMALACIA 23 0.0871
33 FANCONI SYNDROME ACQUIRED 152 0.0865
34 HYPERANDROGENISM 8 0.0851
35 PATHOGEN RESISTANCE 749 0.0821
36 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 22 0.0791
37 HEPATITIS B DNA INCREASED 53 0.0786
38 BLOOD HIV RNA 4 0.0769
39 GENOTYPE DRUG RESISTANCE TEST POSITIVE 78 0.0759
40 HEMIVERTEBRA 12 0.0710
41 SECONDARY SYPHILIS 7 0.0707
42 HEPATITIS B DNA ASSAY POSITIVE 9 0.0703
43 GENETIC POLYMORPHISM 4 0.0702
44 BLOOD HIV RNA INCREASED 121 0.0667
45 FANCONI SYNDROME 94 0.0664
46 MITOCHONDRIAL TOXICITY 54 0.0658
47 THYMUS ENLARGEMENT 10 0.0625
48 AIDS RELATED COMPLICATION 4 0.0615
49 MEDIASTINAL SHIFT 4 0.0597
50 CONGENITAL TERATOMA 5 0.0581
51 CONGENITAL KNEE DEFORMITY 4 0.0556
52 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 6 0.0541
53 DEXTROCARDIA 10 0.0535
54 ECTOPIC KIDNEY 5 0.0526
55 TRISOMY 18 20 0.0525
56 BRACHYDACTYLY 10 0.0508
57 HYDROPS FOETALIS 31 0.0506
58 LIPODYSTROPHY ACQUIRED 105 0.0494
59 ENLARGED CLITORIS 8 0.0485
60 CEREBROVASCULAR ARTERIOVENOUS MALFORMATION 4 0.0460
61 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 221 0.0443
62 IMMUNE RECONSTITUTION SYNDROME 55 0.0426
63 CONGENITAL NAEVUS 6 0.0423
64 GENE MUTATION IDENTIFICATION TEST POSITIVE 17 0.0404
65 RENAL ANEURYSM 9 0.0375
66 HIV TEST POSITIVE 24 0.0363
67 MACROCEPHALY 14 0.0361
68 MENINGOMYELOCELE 21 0.0350
69 HEPATITIS B 201 0.0333
70 GLYCOSURIA 45 0.0333
71 ACUTE HIV INFECTION 8 0.0324
72 MENINGOCELE 5 0.0318
73 ANTI-THYROID ANTIBODY INCREASED 4 0.0317
74 RICKETS 6 0.0317
75 EXTRAOCULAR MUSCLE PARESIS 14 0.0305
76 HETEROTAXIA 5 0.0299
77 RENAL TUBULAR DISORDER 84 0.0298
78 ADRENOGENITAL SYNDROME 4 0.0296
79 CONGENITAL HYDROCEPHALUS 15 0.0296
80 CONGENITAL SKIN DIMPLES 7 0.0290
81 SPINE MALFORMATION 10 0.0288
82 OSTEOMALACIA 44 0.0285
83 HEPATITIS B REACTIVATION 88 0.0277
84 COLLATERAL CIRCULATION 4 0.0276
85 LEFT VENTRICULAR ENLARGEMENT 7 0.0275
86 EXTRAPULMONARY TUBERCULOSIS 8 0.0271
87 ACUTE HEPATITIS B 9 0.0271
88 ACQUIRED GENE MUTATION 35 0.0267
89 PORTAL HYPERTENSIVE GASTROPATHY 15 0.0266
90 BONE METABOLISM DISORDER 8 0.0266
91 NEUROSYPHILIS 4 0.0263
92 ANION GAP ABNORMAL 7 0.0261
93 ACQUIRED IMMUNODEFICIENCY SYNDROME 13 0.0250
94 ANKYLOGLOSSIA CONGENITAL 10 0.0249
95 PORTAL VENOUS GAS 9 0.0248
96 LARYNGOMALACIA 8 0.0239
97 NON-ALCOHOLIC FATTY LIVER 8 0.0237
98 MESENTERIC ARTERY THROMBOSIS 9 0.0234
99 PORPHYRIA NON-ACUTE 10 0.0230
100 RENAL HYPOPLASIA 5 0.0229
101 VIRAL LOAD INCREASED 89 0.0229
102 MICROGNATHIA 11 0.0220
103 CD4 LYMPHOCYTES DECREASED 47 0.0219
104 HEPATITIS B SURFACE ANTIGEN POSITIVE 6 0.0219
105 CLEFT LIP AND PALATE 24 0.0215
106 TRISOMY 21 27 0.0214
107 NON-CIRRHOTIC PORTAL HYPERTENSION 8 0.0213
108 GASTRIC VARICES 10 0.0212
109 CENTRAL NERVOUS SYSTEM INFLAMMATION 7 0.0211
110 NEURAL TUBE DEFECT 15 0.0206
111 CUSHING'S SYNDROME 14 0.0201
112 PLACENTAL INSUFFICIENCY 16 0.0199
113 DRUG RESISTANCE 501 0.0195
114 LOW SET EARS 8 0.0195
115 RENAL TUBULAR ACIDOSIS 42 0.0192
116 STILLBIRTH 91 0.0188
117 SKULL MALFORMATION 12 0.0187
118 NEPHROPATHY TOXIC 206 0.0183
119 MALARIA 12 0.0170
120 ARNOLD-CHIARI MALFORMATION 16 0.0168
121 RETINAL TOXICITY 17 0.0165
122 INFECTIVE ANEURYSM 8 0.0162
123 OESOPHAGEAL ATRESIA 10 0.0160
124 HYDROCELE 17 0.0159
125 MITOCHONDRIAL CYTOPATHY 7 0.0159
126 BONE TUBERCULOSIS 6 0.0157
127 MULTIPLE-DRUG RESISTANCE 48 0.0155
128 PSYCHIATRIC DECOMPENSATION 30 0.0153
129 NASOPHARYNGEAL CANCER 4 0.0153
130 BENIGN HYDATIDIFORM MOLE 5 0.0151
131 DISEASE RISK FACTOR 6 0.0149
132 NECROTISING ENTEROCOLITIS NEONATAL 6 0.0148
133 OPHTHALMOPLEGIA 23 0.0146
134 BLOOD CORTICOTROPHIN DECREASED 7 0.0143
135 HYPERSPLENISM 7 0.0141
136 HIV INFECTION 42 0.0139
137 CSF TEST ABNORMAL 7 0.0139
138 HEPATIC ARTERY THROMBOSIS 4 0.0137
139 ADRENAL SUPPRESSION 11 0.0130
140 POLYDACTYLY 15 0.0129
141 CYTOMEGALOVIRUS CHORIORETINITIS 25 0.0128
142 BLOOD PHOSPHORUS ABNORMAL 6 0.0127
143 CHRONIC HEPATITIS C 5 0.0127
144 ANOMALY OF EXTERNAL EAR CONGENITAL 4 0.0127
145 VANISHING BILE DUCT SYNDROME 14 0.0126
146 HYPERPHOSPHATAEMIA 27 0.0125
147 MENINGITIS TUBERCULOUS 7 0.0125
148 ABDOMINAL SEPSIS 11 0.0125
149 LUNG TRANSPLANT REJECTION 8 0.0121
150 HYPERBILIRUBINAEMIA NEONATAL 7 0.0120
151 PLAGIOCEPHALY 6 0.0120
152 PROTRUSION TONGUE 7 0.0120
153 MICROALBUMINURIA 9 0.0119
154 BLOOD TRIGLYCERIDES DECREASED 4 0.0119
155 HEPATITIS C RNA INCREASED 4 0.0117
156 PLACENTAL DISORDER 11 0.0116
157 VIRAEMIA 16 0.0115
158 LIPOHYPERTROPHY 7 0.0113
159 ANAL ATRESIA 6 0.0112
160 HYPOPHOSPHATAEMIA 83 0.0112
161 EXOMPHALOS 6 0.0112
162 SEPSIS NEONATAL 9 0.0111
163 PSYCHOMOTOR SKILLS IMPAIRED 29 0.0111
164 SYPHILIS 8 0.0110
165 LIVER TRANSPLANT 40 0.0110
166 NECROTISING RETINITIS 7 0.0109
167 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 12 0.0109
168 NODULAR REGENERATIVE HYPERPLASIA 7 0.0109
169 VARICES OESOPHAGEAL 33 0.0109
170 CHOLESTASIS OF PREGNANCY 5 0.0109
171 MENINGITIS CRYPTOCOCCAL 18 0.0103
172 JOINT HYPEREXTENSION 4 0.0103
173 GENE MUTATION 20 0.0101
174 PORTAL HYPERTENSION 31 0.0100
175 KAPOSI'S SARCOMA 5 0.0100
176 PANCREATITIS RELAPSING 8 0.0098
177 VISCERAL LEISHMANIASIS 7 0.0097
178 DIAPHRAGMATIC HERNIA 6 0.0097
179 SPINA BIFIDA 20 0.0096
180 GLOMERULOSCLEROSIS 6 0.0095
181 LIPOATROPHY 9 0.0095
182 VOLVULUS 22 0.0093
183 FOETAL GROWTH RESTRICTION 56 0.0092
184 HEPATOCELLULAR CARCINOMA 69 0.0091
185 FOETAL EXPOSURE DURING PREGNANCY 727 0.0089
186 PULMONARY TUBERCULOSIS 38 0.0089
187 PROTEIN URINE 8 0.0088
188 MENTAL DISABILITY 5 0.0087
189 GRAVITATIONAL OEDEMA 6 0.0086
190 PLEOCYTOSIS 5 0.0086
191 CEREBRAL TOXOPLASMOSIS 8 0.0086
192 BLOOD PHOSPHORUS DECREASED 31 0.0085
193 CRYSTAL NEPHROPATHY 5 0.0084
194 DEVELOPMENTAL HIP DYSPLASIA 7 0.0084
195 DEPRESSION SUICIDAL 29 0.0084
196 BLOOD URIC ACID DECREASED 4 0.0082
197 DEPRESSIVE SYMPTOM 29 0.0082
198 VENTRICULAR SEPTAL DEFECT 47 0.0082
199 DRUG LEVEL CHANGED 5 0.0079
200 LYMPHOCYTIC INFILTRATION 8 0.0079
201 CONGENITAL ANOMALY 61 0.0079
202 OSTEOPOROTIC FRACTURE 15 0.0078
203 BLOOD ALBUMIN ABNORMAL 4 0.0077
204 C-REACTIVE PROTEIN DECREASED 5 0.0077
205 PULMONARY HYPOPLASIA 6 0.0076
206 FOETAL HEART RATE ABNORMAL 7 0.0076
207 LIVE BIRTH 63 0.0075
208 CONGENITAL NOSE MALFORMATION 4 0.0075
209 FOETAL EXPOSURE DURING DELIVERY 5 0.0074
210 OESOPHAGEAL VARICES HAEMORRHAGE 16 0.0074
211 METABOLIC SYNDROME 12 0.0073
212 LOW BIRTH WEIGHT BABY 58 0.0073
213 TEARFULNESS 31 0.0072
214 DEATH NEONATAL 10 0.0072
215 TWIN PREGNANCY 6 0.0071
216 CRYPTORCHISM 8 0.0071
217 SJS-TEN OVERLAP 5 0.0071
218 ANENCEPHALY 4 0.0071
219 NEONATAL RESPIRATORY DISTRESS SYNDROME 25 0.0071
220 HEPATIC FIBROSIS 24 0.0070
221 CARDIAC VENTRICULAR THROMBOSIS 9 0.0070
222 OSTEOCHONDROSIS 8 0.0069
223 ABORTION SPONTANEOUS 268 0.0067
224 DISSEMINATED TUBERCULOSIS 17 0.0066
225 HUMAN HERPESVIRUS 8 INFECTION 4 0.0066
226 OESOPHAGEAL CANDIDIASIS 26 0.0065
227 PORTAL VEIN THROMBOSIS 21 0.0065
228 DYSLIPIDAEMIA 33 0.0065
229 BLOOD BILIRUBIN DECREASED 4 0.0065
230 ATYPICAL MYCOBACTERIAL INFECTION 9 0.0064
231 NECROTISING COLITIS 8 0.0063
232 HYPERCHLORAEMIA 4 0.0063
233 PREMATURE RUPTURE OF MEMBRANES 15 0.0062
234 RENAL INFARCT 9 0.0062
235 NEPHROGENIC DIABETES INSIPIDUS 7 0.0061
236 PSYCHOMOTOR RETARDATION 17 0.0060
237 SYNDACTYLY 5 0.0060
238 CAESAREAN SECTION 69 0.0059
239 OSTEOPOROSIS 243 0.0059
240 ENCEPHALITIS VIRAL 7 0.0057
241 EYELID PTOSIS 58 0.0057
242 HILAR LYMPHADENOPATHY 5 0.0057
243 INTERMITTENT CLAUDICATION 9 0.0057
244 FOETAL DISTRESS SYNDROME 12 0.0057
245 RENAL ATROPHY 7 0.0056
246 CONGENITAL HYDRONEPHROSIS 4 0.0056
247 PREMATURE DELIVERY 89 0.0056
248 MYCOBACTERIUM AVIUM COMPLEX INFECTION 15 0.0056
249 LIPIDS ABNORMAL 4 0.0055
250 PNEUMOCYSTIS JIROVECI PNEUMONIA 12 0.0054
251 PREMATURE BABY 160 0.0053
252 RENAL TUBULAR NECROSIS 52 0.0053
253 ANAEMIA MACROCYTIC 11 0.0051
254 OLIGOHYDRAMNIOS 17 0.0051
255 HEPATOSPLENOMEGALY 13 0.0051
256 PYURIA 5 0.0051
257 SMALL FOR DATES BABY 25 0.0050
258 HIGH DENSITY LIPOPROTEIN INCREASED 5 0.0050
259 PREMATURE LABOUR 28 0.0049
260 NEUROLOGICAL SYMPTOM 28 0.0049
261 DYSBIOSIS 4 0.0049
262 RENAL COLIC 11 0.0049
263 ATRIAL SEPTAL DEFECT 40 0.0048
264 GENERALISED ANXIETY DISORDER 7 0.0048
265 WHITE MATTER LESION 6 0.0047
266 PNEUMONIA PNEUMOCOCCAL 7 0.0047
267 MATERNAL DRUGS AFFECTING FOETUS 36 0.0047
268 HEPATIC CIRRHOSIS 86 0.0046
269 MATERNAL EXPOSURE DURING PREGNANCY 393 0.0044
270 INFECTION REACTIVATION 5 0.0044
271 PROTEINURIA 83 0.0044
272 CEREBRAL VENTRICLE DILATATION 5 0.0043
273 DYSMORPHISM 10 0.0042
274 ECTOPIC PREGNANCY 13 0.0042
275 HEPATORENAL SYNDROME 7 0.0041
276 RENAL TUBULAR INJURY 5 0.0041
277 EPIDERMAL NECROSIS 4 0.0041
278 GLOMERULONEPHRITIS 10 0.0041
279 ABORTION INDUCED 38 0.0040
280 GLOMERULAR FILTRATION RATE DECREASED 49 0.0040
281 ABORTION MISSED 5 0.0039
282 EXPOSURE DURING PREGNANCY 243 0.0039
283 FIBROSIS 12 0.0039
284 HYPOSPADIAS 8 0.0038
285 OBLITERATIVE BRONCHIOLITIS 5 0.0038
286 REBOUND EFFECT 43 0.0038
287 TREATMENT NONCOMPLIANCE 208 0.0038
288 HYPERBILIRUBINAEMIA 39 0.0038
289 HYPERTENSIVE NEPHROPATHY 4 0.0037
290 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6 0.0037
291 PATHOLOGICAL FRACTURE 19 0.0037
292 HEPATITIS FULMINANT 11 0.0037
293 BLOOD BICARBONATE DECREASED 7 0.0037
294 CACHEXIA 19 0.0037
295 HEPATIC CYTOLYSIS 47 0.0037
296 OPTIC ATROPHY 6 0.0037
297 CRYPTOCOCCOSIS 6 0.0037
298 FOETAL DEATH 19 0.0037
299 LYMPHADENOPATHY MEDIASTINAL 7 0.0037
300 DRUG LEVEL BELOW THERAPEUTIC 20 0.0036
301 TREATMENT FAILURE 300 0.0036
302 MYELITIS TRANSVERSE 5 0.0035
303 CHRONIC GASTRITIS 8 0.0035
304 TALIPES 11 0.0035
305 KIDNEY FIBROSIS 6 0.0035
306 LABELLED DRUG-DRUG INTERACTION ISSUE 5 0.0035
307 HEPATITIS TOXIC 9 0.0035
308 LUNG OPACITY 9 0.0034
309 HISTOPLASMOSIS 6 0.0034
310 COCCIDIOIDOMYCOSIS 4 0.0034
311 DRUG-INDUCED LIVER INJURY 105 0.0033
312 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 4 0.0033
313 EXPOSURE VIA BREAST MILK 13 0.0033
314 VITRITIS 6 0.0032
315 APLASIA PURE RED CELL 11 0.0032
316 OSTEOSCLEROSIS 5 0.0032
317 NEPHRITIS INTERSTITIAL 4 0.0032
318 GLUCOSE URINE PRESENT 4 0.0031
319 CUSHINGOID 10 0.0031
320 HEART DISEASE CONGENITAL 11 0.0031
321 CYTOMEGALOVIRUS COLITIS 7 0.0030
322 AUTOIMMUNE HEPATITIS 21 0.0030
323 HEPATIC FAILURE 90 0.0030
324 MYCOBACTERIAL INFECTION 5 0.0029
325 HEPATITIS C 35 0.0029
326 BLOOD LACTIC ACID INCREASED 15 0.0028
327 PROTEIN URINE PRESENT 14 0.0028
328 HYPERPARATHYROIDISM SECONDARY 7 0.0028
329 OSTEOPENIA 42 0.0028
330 CEREBELLAR SYNDROME 6 0.0027
331 BILIARY DILATATION 4 0.0027
332 RENAL IMPAIRMENT 227 0.0027
333 HEPATIC NECROSIS 10 0.0027
334 MARASMUS 4 0.0026
335 LICHENOID KERATOSIS 6 0.0026
336 HEPATIC MASS 5 0.0026
337 ATROPHY 5 0.0026
338 NASAL SEPTUM DEVIATION 5 0.0026
339 OCULAR ICTERUS 11 0.0025
340 INHIBITORY DRUG INTERACTION 4 0.0025
341 LIMB DEFORMITY 4 0.0025
342 RENAL TRANSPLANT 9 0.0025
343 BLOOD CREATININE INCREASED 160 0.0024
344 ALANINE AMINOTRANSFERASE INCREASED 149 0.0024
345 ILLUSION 4 0.0024
346 IGA NEPHROPATHY 4 0.0024
347 HISTIOCYTOSIS HAEMATOPHAGIC 7 0.0024
348 FOOD AVERSION 4 0.0024
349 GAZE PALSY 4 0.0023
350 HEPATIC CANCER 56 0.0023
351 ENCEPHALITIS 16 0.0023
352 DIPLOPIA 60 0.0023
353 PROCEDURAL HAEMORRHAGE 9 0.0023
354 PREGNANCY ON ORAL CONTRACEPTIVE 6 0.0023
355 INTRA-ABDOMINAL FLUID COLLECTION 4 0.0022
356 BLOOD PHOSPHORUS INCREASED 6 0.0022
357 PREGNANCY 44 0.0022
358 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 18 0.0022
359 EUGLYCAEMIC DIABETIC KETOACIDOSIS 9 0.0022
360 BLOOD CHOLESTEROL DECREASED 4 0.0021
361 HEPATIC NEOPLASM 7 0.0021
362 DRUG INTERACTION 339 0.0021
363 SPLENOMEGALY 25 0.0021
364 NASAL OBSTRUCTION 4 0.0021
365 TRANSPLANT REJECTION 17 0.0021
366 CONTRAINDICATED PRODUCT ADMINISTERED 64 0.0021
367 DIABETES INSIPIDUS 5 0.0021
368 RENAL FAILURE ACUTE 88 0.0021
369 HYPERTRIGLYCERIDAEMIA 12 0.0020
370 STRABISMUS 6 0.0020
371 HEPATIC ENCEPHALOPATHY 19 0.0020
372 ASPARTATE AMINOTRANSFERASE INCREASED 108 0.0020
373 BRAIN HERNIATION 6 0.0020
374 HYPERPHAGIA 8 0.0020
375 CAROTID ARTERY STENOSIS 7 0.0020
376 LIPIDS INCREASED 4 0.0020
377 FACIAL PARESIS 7 0.0020
378 SKIN HYPERPIGMENTATION 17 0.0020
379 POLYURIA 16 0.0020
380 VITAMIN D DEFICIENCY 19 0.0019
381 HYPERPARATHYROIDISM 4 0.0019
382 UMBILICAL HERNIA 9 0.0019
383 LUNG ABSCESS 4 0.0019
384 ALANINE AMINOTRANSFERASE ABNORMAL 4 0.0019
385 GESTATIONAL DIABETES 9 0.0019
386 AREFLEXIA 5 0.0019
387 EXOPHTHALMOS 4 0.0019
388 TOOTH INJURY 8 0.0018
389 BACTERIAL SEPSIS 6 0.0018
390 NORMAL NEWBORN 10 0.0018
391 DIABETIC NEPHROPATHY 4 0.0018
392 HEPATITIS 46 0.0018
393 NECROSIS 10 0.0018
394 HEPATOTOXICITY 40 0.0018
395 OSTEONECROSIS 59 0.0018
396 PNEUMOCYSTIS JIROVECII PNEUMONIA 18 0.0018
397 CHOLANGITIS 11 0.0018
398 LACTIC ACIDOSIS 57 0.0018
399 CREATININE RENAL CLEARANCE DECREASED 7 0.0017
400 PARANOIA 30 0.0017
401 HYPOVOLAEMIA 10 0.0017
402 BONE EROSION 6 0.0017
403 CREPITATIONS 5 0.0017
404 HAEMOLYTIC ANAEMIA 15 0.0017
405 ORAL CANDIDIASIS 22 0.0017
406 CHRONIC KIDNEY DISEASE 126 0.0017
407 INTESTINAL ISCHAEMIA 9 0.0016
408 BLOOD CREATINE PHOSPHOKINASE INCREASED 47 0.0016
409 PARADOXICAL DRUG REACTION 6 0.0016
410 BLOOD BILIRUBIN INCREASED 44 0.0016
411 METABOLIC ACIDOSIS 52 0.0016
412 ACUTE HEPATIC FAILURE 22 0.0016
413 NEPHROPATHY 15 0.0016
414 DERMATITIS EXFOLIATIVE 8 0.0016
415 BLOOD CREATINE INCREASED 7 0.0016
416 SKIN LESION 43 0.0016
417 MENINGITIS ASEPTIC 7 0.0016
418 LOW DENSITY LIPOPROTEIN INCREASED 12 0.0015
419 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0015
420 HYPERSENSITIVITY VASCULITIS 4 0.0015
421 BLOOD ALBUMIN DECREASED 12 0.0015
422 EXPOSURE DURING BREAST FEEDING 5 0.0015
423 LIVER INJURY 37 0.0015
424 CYTOLYTIC HEPATITIS 5 0.0015
425 ALCOHOL POISONING 4 0.0015
426 HYPERLACTACIDAEMIA 4 0.0015
427 BK VIRUS INFECTION 5 0.0015
428 DRUG LEVEL DECREASED 15 0.0015
429 B-CELL LYMPHOMA 5 0.0015
430 LUNG INFILTRATION 13 0.0015
431 HYDROCEPHALUS 8 0.0015
432 PSYCHOTIC DISORDER 43 0.0015
433 ACIDOSIS 11 0.0014
434 GASTROENTERITIS 21 0.0014
435 INTRACRANIAL PRESSURE INCREASED 8 0.0014
436 FRACTURE 27 0.0014
437 SLEEP TERROR 6 0.0014
438 HEPATOMEGALY 14 0.0014
439 SKIN PLAQUE 12 0.0014
440 STAPHYLOCOCCAL SEPSIS 7 0.0014
441 JAUNDICE 38 0.0014
442 RASH MACULO-PAPULAR 31 0.0014
443 HEPATIC LESION 6 0.0014
444 TUBULOINTERSTITIAL NEPHRITIS 26 0.0014
445 BONE LESION 5 0.0014
446 SOCIAL AVOIDANT BEHAVIOUR 8 0.0014
447 RALES 8 0.0014
448 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
449 HEPATIC FUNCTION ABNORMAL 50 0.0013
450 HYDRONEPHROSIS 10 0.0013
451 ASCITES 39 0.0013
452 DRUG EXPOSURE DURING PREGNANCY 45 0.0013
453 CHEMOTHERAPY 5 0.0013
454 EYE MOVEMENT DISORDER 9 0.0013
455 MASTICATION DISORDER 4 0.0013
456 PREGNANCY WITH IMPLANT CONTRACEPTIVE 6 0.0013
457 PAPULE 9 0.0013
458 BRAIN OEDEMA 16 0.0013
459 POLYDIPSIA 5 0.0013
460 END STAGE RENAL DISEASE 23 0.0013
461 BILE DUCT STONE 4 0.0013
462 IMMUNOSUPPRESSION 11 0.0012
463 BLOOD TRIGLYCERIDES INCREASED 22 0.0012
464 ADRENAL INSUFFICIENCY 15 0.0012
465 DRUG INTOLERANCE 119 0.0012
466 PERIPHERAL VENOUS DISEASE 5 0.0012
467 HERPES VIRUS INFECTION 7 0.0012
468 LYMPHADENOPATHY 42 0.0012
469 HEPATIC PAIN 5 0.0012
470 ALCOHOLISM 5 0.0012
471 MALNUTRITION 13 0.0012
472 HAEMATOTOXICITY 11 0.0012
473 ACUTE KIDNEY INJURY 177 0.0012
474 SKIN NECROSIS 6 0.0012
475 GRANULOMA 4 0.0012
476 LIVER DISORDER 51 0.0011
477 AORTIC STENOSIS 4 0.0011
478 DRUG LEVEL INCREASED 19 0.0011
479 BLOOD UREA INCREASED 19 0.0011
480 NYSTAGMUS 6 0.0011
481 BLOOD ALKALINE PHOSPHATASE INCREASED 28 0.0011
482 HEPATIC STEATOSIS 21 0.0011
483 STEVENS-JOHNSON SYNDROME 25 0.0011
484 HAEMORRHAGIC DIATHESIS 4 0.0011
485 STRESS FRACTURE 6 0.0011
486 LIVER FUNCTION TEST ABNORMAL 32 0.0011
487 LYMPHOMA 17 0.0011
488 CUTANEOUS VASCULITIS 4 0.0011
489 NEUROTOXICITY 19 0.0011
490 TRANSAMINASES INCREASED 24 0.0011
491 RENAL INJURY 32 0.0011
492 BRADYPHRENIA 7 0.0011
493 ARTERIOSCLEROSIS 10 0.0011
494 RHABDOMYOLYSIS 44 0.0011
495 SPINAL FRACTURE 21 0.0010
496 SUBCUTANEOUS ABSCESS 5 0.0010
497 MYOPATHY 9 0.0010
498 NEPHROTIC SYNDROME 7 0.0010
499 MASS 14 0.0010
500 AZOTAEMIA 4 0.0010
501 TYPE 1 DIABETES MELLITUS 6 0.0010
502 FOOT DEFORMITY 11 0.0010
503 DUODENAL ULCER 7 0.0010
504 MYASTHENIA GRAVIS 8 0.0010
505 PNEUMONIA BACTERIAL 9 0.0010
506 TYPE 2 DIABETES MELLITUS 33 0.0010
507 LIVER FUNCTION TEST INCREASED 21 0.0010
508 ARTHRITIS BACTERIAL 4 0.0010
509 STATUS EPILEPTICUS 11 0.0010
510 HYPERURICAEMIA 4 0.0010
511 VISUAL FIELD DEFECT 7 0.0010
512 ANAEMIA 184 0.0010
513 BONE DENSITY DECREASED 30 0.0010
514 TACHYPNOEA 13 0.0010
515 CENTRAL NERVOUS SYSTEM LESION 13 0.0009
516 RENAL FAILURE 124 0.0009
517 PSEUDOMONAS INFECTION 8 0.0009
518 HYPERCHOLESTEROLAEMIA 9 0.0009
519 DIABETES MELLITUS 71 0.0009
520 CHROMATURIA 21 0.0009
521 PARKINSONISM 9 0.0009
522 DIALYSIS 13 0.0009
523 PANCYTOPENIA 51 0.0009
524 DIFFUSE LARGE B-CELL LYMPHOMA 7 0.0009
525 RHEUMATOID ARTHRITIS 103 0.0009
526 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 8 0.0009
527 PELVIC FRACTURE 7 0.0009
528 FOOT FRACTURE 17 0.0009
529 DERMATITIS ALLERGIC 11 0.0009
530 IMMUNE THROMBOCYTOPENIA 4 0.0009
531 SHOCK 20 0.0009
532 BLOOD URIC ACID INCREASED 5 0.0009
533 SHOCK HAEMORRHAGIC 7 0.0009
534 GAMMA-GLUTAMYLTRANSFERASE INCREASED 19 0.0009
535 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
536 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 22 0.0009
537 SUDDEN DEATH 9 0.0008
538 NEPHROLITHIASIS 39 0.0008
539 SQUAMOUS CELL CARCINOMA 8 0.0008
540 NEUTROPENIC SEPSIS 6 0.0008
541 CHOLECYSTITIS 10 0.0008
542 ODYNOPHAGIA 5 0.0008
543 PROTHROMBIN TIME PROLONGED 5 0.0008
544 HYPOVOLAEMIC SHOCK 4 0.0008
545 RESPIRATORY DISTRESS 23 0.0008
546 CHOLESTASIS 16 0.0008
547 ENTEROCOCCAL INFECTION 4 0.0008
548 RIB FRACTURE 17 0.0008
549 PERICARDIAL EFFUSION 19 0.0008
550 ORAL DISORDER 6 0.0008
551 GENERALISED OEDEMA 10 0.0008
552 OLIGURIA 5 0.0008
553 HYPERNATRAEMIA 4 0.0008
554 HEPATIC ENZYME ABNORMAL 4 0.0008
555 EOSINOPHILIA 14 0.0008
556 KLEBSIELLA INFECTION 4 0.0008
557 CHOLECYSTECTOMY 9 0.0008
558 LIPASE INCREASED 6 0.0008
559 CYTOMEGALOVIRUS INFECTION 13 0.0008
560 RENAL FAILURE CHRONIC 6 0.0008
561 THERAPY NON-RESPONDER 35 0.0008
562 NERVOUS SYSTEM DISORDER 24 0.0008
563 MALABSORPTION 4 0.0008
564 RENAL CYST 6 0.0008
565 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
566 TREMOR 125 0.0008
567 POLYNEUROPATHY 9 0.0008
568 LEUKAEMIA 7 0.0007
569 HYPOKALAEMIA 34 0.0007
570 GASTRIC ULCER 14 0.0007
571 DRUG ERUPTION 13 0.0007
572 DEAFNESS UNILATERAL 4 0.0007
573 GENERALISED TONIC-CLONIC SEIZURE 12 0.0007
574 ANGIOPATHY 4 0.0007
575 BONE DISORDER 13 0.0007
576 CIRCULATORY COLLAPSE 12 0.0007
577 GENERALISED ERYTHEMA 4 0.0007
578 ANOREXIA 9 0.0007
579 ANURIA 6 0.0007
580 MULTI-ORGAN FAILURE 12 0.0007
581 CARDIAC MURMUR 6 0.0007
582 BONE MARROW FAILURE 14 0.0007
583 BRADYKINESIA 4 0.0007
584 CEREBRAL DISORDER 5 0.0007
585 PRESCRIBED OVERDOSE 13 0.0007
586 MULTIPLE ORGAN DYSFUNCTION SYNDROME 19 0.0007
587 HAEMATEMESIS 17 0.0007
588 MULTIPLE FRACTURES 11 0.0007
589 HYPERLIPIDAEMIA 8 0.0007
590 NEURALGIA 16 0.0007
591 INTENTIONAL PRODUCT USE ISSUE 57 0.0007
592 CARDIOMEGALY 8 0.0006
593 DEAFNESS 17 0.0006
594 LARYNGEAL OEDEMA 4 0.0006
595 APHTHOUS ULCER 5 0.0006
596 DISEASE RECURRENCE 30 0.0006
597 ABSCESS 10 0.0006
598 SENSORY DISTURBANCE 10 0.0006
599 RENAL DISORDER 29 0.0006
600 MOUTH ULCERATION 13 0.0006
601 FEMUR FRACTURE 19 0.0006
602 ENCEPHALOPATHY 15 0.0006
603 MYELOSUPPRESSION 22 0.0006
604 GASTRITIS 16 0.0006
605 IMMUNE SYSTEM DISORDER 8 0.0006
606 SPINAL COMPRESSION FRACTURE 5 0.0006
607 HYPOTONIA 6 0.0006
608 MENINGITIS 4 0.0006
609 ATRIOVENTRICULAR BLOCK COMPLETE 4 0.0006
610 SLUGGISHNESS 6 0.0006
611 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
612 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
613 ABNORMAL DREAMS 16 0.0006
614 PANCREATITIS ACUTE 13 0.0006
615 PYELONEPHRITIS 5 0.0006
616 NO THERAPEUTIC RESPONSE 7 0.0006
617 TUMOUR LYSIS SYNDROME 5 0.0006
618 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
619 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
620 HYPERCALCAEMIA 7 0.0006
621 MUSCLE ATROPHY 7 0.0006
622 OPTIC NEURITIS 5 0.0005
623 PHOTOSENSITIVITY REACTION 9 0.0005
624 BRAIN NEOPLASM 5 0.0005
625 GRAND MAL CONVULSION 5 0.0005
626 DIABETIC KETOACIDOSIS 13 0.0005
627 RASH GENERALISED 14 0.0005
628 VENTRICULAR FIBRILLATION 6 0.0005
629 NODULE 7 0.0005
630 CONDITION AGGRAVATED 163 0.0005
631 RASH PAPULAR 12 0.0005
632 SUICIDAL IDEATION 49 0.0005
633 FLANK PAIN 5 0.0005
634 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
635 MYOCARDITIS 6 0.0005
636 EYELID OEDEMA 6 0.0005
637 POST PROCEDURAL HAEMORRHAGE 6 0.0005
638 STAPHYLOCOCCAL INFECTION 17 0.0005
639 HYPOALBUMINAEMIA 4 0.0005
640 DRUG TOXICITY 7 0.0005
641 SEPSIS 57 0.0005
642 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
643 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
644 ATAXIA 6 0.0005
645 MENTAL DISORDER 22 0.0005
646 PNEUMOTHORAX 8 0.0005
647 ULCER 8 0.0005
648 NEOPLASM MALIGNANT 33 0.0005
649 THROMBOCYTOPENIA 55 0.0005
650 SUBDURAL HAEMATOMA 7 0.0005
651 RASH MACULAR 17 0.0005
652 TEMPERATURE INTOLERANCE 5 0.0005
653 AGRANULOCYTOSIS 9 0.0005
654 PHARYNGITIS 6 0.0005
655 NEUROPATHY PERIPHERAL 46 0.0005
656 HYPERTHYROIDISM 7 0.0005
657 ILEUS 6 0.0005
658 HYPOXIA 17 0.0005
659 PYREXIA 167 0.0005
660 VISUAL ACUITY REDUCED 16 0.0005
661 EOSINOPHIL COUNT INCREASED 4 0.0005
662 PLATELET COUNT DECREASED 51 0.0005
663 FOLLICULITIS 5 0.0005
664 HAEMODIALYSIS 4 0.0005
665 HEPATIC ENZYME INCREASED 32 0.0005
666 GLAUCOMA 9 0.0005
667 BONE LOSS 7 0.0005
668 NIGHT SWEATS 15 0.0005
669 HAEMOGLOBIN DECREASED 47 0.0005
670 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
671 LUNG INFECTION 7 0.0005
672 SKIN DISORDER 15 0.0004
673 BASAL CELL CARCINOMA 7 0.0004
674 GASTROINTESTINAL DISORDER 40 0.0004
675 MYOSITIS 4 0.0004
676 ELECTROCARDIOGRAM QT PROLONGED 16 0.0004
677 BLOOD CALCIUM DECREASED 5 0.0004
678 PALLOR 12 0.0004
679 OBESITY 7 0.0004
680 HYPERGLYCAEMIA 16 0.0004
681 METASTASES TO LUNG 5 0.0004
682 DELIRIUM 15 0.0004
683 ELECTROLYTE IMBALANCE 5 0.0004
684 ERYTHEMA MULTIFORME 4 0.0004
685 SKIN ULCER 11 0.0004
686 HEPATOCELLULAR INJURY 6 0.0004
687 HYPOCALCAEMIA 8 0.0004
688 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 30 0.0004
689 BACTERAEMIA 5 0.0004
690 COAGULOPATHY 7 0.0004
691 WRIST FRACTURE 5 0.0004
692 LOWER LIMB FRACTURE 8 0.0004
693 DEPRESSED MOOD 22 0.0004
694 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
695 TOXICITY TO VARIOUS AGENTS 70 0.0004
696 SEPTIC SHOCK 18 0.0004
697 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
698 SCHIZOPHRENIA 5 0.0004
699 ANGIOEDEMA 18 0.0004
700 KNEE OPERATION 4 0.0004
701 DECREASED APPETITE 94 0.0004
702 NIGHTMARE 14 0.0004
703 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
704 LEUKOPENIA 20 0.0004
705 POISONING 5 0.0004
706 BLINDNESS 16 0.0004
707 DYSPHAGIA 37 0.0004
708 SYNOVITIS 7 0.0004
709 TOOTH LOSS 8 0.0004
710 PRODUCTIVE COUGH 18 0.0004
711 HYPOTHYROIDISM 12 0.0004
712 HAIR TEXTURE ABNORMAL 5 0.0004
713 POOR QUALITY SLEEP 8 0.0004
714 HYPERKALAEMIA 13 0.0004
715 ABDOMINAL DISTENSION 38 0.0004
716 CORONARY ARTERY DISEASE 11 0.0004
717 DEHYDRATION 48 0.0004
718 HAEMOPTYSIS 10 0.0004
719 HEMIPARESIS 6 0.0004
720 LYMPHOPENIA 5 0.0004
721 NEUTROPENIA 48 0.0004
722 ERECTILE DYSFUNCTION 9 0.0004
723 PARALYSIS 5 0.0003
724 PRODUCT PHYSICAL ISSUE 7 0.0003
725 NEOPLASM PROGRESSION 12 0.0003
726 NEUTROPHIL COUNT DECREASED 14 0.0003
727 RESPIRATORY FAILURE 25 0.0003
728 HIP FRACTURE 11 0.0003
729 WHITE BLOOD CELL COUNT DECREASED 37 0.0003
730 HEADACHE 211 0.0003
731 DRUG ABUSE 28 0.0003
732 THIRST 6 0.0003
733 MYOCLONUS 4 0.0003
734 RASH ERYTHEMATOUS 16 0.0003
735 DRUG INEFFECTIVE 441 0.0003
736 CONFUSIONAL STATE 54 0.0003
737 FEBRILE NEUTROPENIA 22 0.0003
738 NOCTURIA 4 0.0003
739 PLEURAL EFFUSION 20 0.0003
740 IMPAIRED WORK ABILITY 7 0.0003
741 ABDOMINAL PAIN 76 0.0003
742 LUNG DISORDER 16 0.0003
743 MYALGIA 55 0.0003
744 CONJUNCTIVITIS 6 0.0003
745 VOMITING 152 0.0003
746 FAECES DISCOLOURED 7 0.0003
747 DYSARTHRIA 12 0.0003
748 DEPRESSION 72 0.0003
749 WEIGHT DECREASED 88 0.0003
750 COMA 15 0.0003
751 ASTHENIA 118 0.0003
752 OEDEMA 17 0.0003
753 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
754 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
755 BLOOD POTASSIUM INCREASED 5 0.0003
756 CEREBRAL HAEMORRHAGE 11 0.0003
757 MUCOSAL INFLAMMATION 8 0.0003
758 ACUTE MYOCARDIAL INFARCTION 9 0.0003
759 COGNITIVE DISORDER 14 0.0003
760 SUICIDE ATTEMPT 18 0.0003
761 SKIN EXFOLIATION 25 0.0003
762 CANDIDA INFECTION 5 0.0003
763 DEATH 253 0.0003
764 GYNAECOMASTIA 9 0.0003
765 BONE PAIN 17 0.0003
766 LOCAL SWELLING 5 0.0003
767 MYOCARDIAL INFARCTION 50 0.0003
768 DEMENTIA 8 0.0003
769 MOVEMENT DISORDER 9 0.0003
770 ANGINA PECTORIS 8 0.0003
771 MYELODYSPLASTIC SYNDROME 4 0.0003
772 HYPOKINESIA 4 0.0003
773 C-REACTIVE PROTEIN INCREASED 10 0.0003
774 CHOLELITHIASIS 9 0.0003
775 HYPOPHAGIA 7 0.0003
776 DYSURIA 10 0.0003
777 VIRAL INFECTION 9 0.0003
778 OESOPHAGEAL CARCINOMA 8 0.0003
779 DIARRHOEA 171 0.0003
780 APHASIA 8 0.0003
781 MUSCULAR WEAKNESS 30 0.0003
782 COLITIS 10 0.0003
783 HAEMATURIA 9 0.0003
784 EPILEPSY 8 0.0003
785 EJECTION FRACTION DECREASED 4 0.0003
786 OEDEMA PERIPHERAL 31 0.0003
787 HAEMATOCHEZIA 14 0.0003
788 THERAPY CESSATION 13 0.0003
789 INFLAMMATION 13 0.0003
790 GASTROINTESTINAL HAEMORRHAGE 21 0.0003
791 PANIC ATTACK 9 0.0002
792 PANCREATITIS 13 0.0002
793 SWELLING FACE 16 0.0002
794 CEREBRAL INFARCTION 6 0.0002
795 CARDIAC ARREST 20 0.0002
796 CEREBROVASCULAR ACCIDENT 41 0.0002
797 GENERAL PHYSICAL HEALTH DETERIORATION 28 0.0002
798 PALPITATIONS 28 0.0002
799 ADVERSE EVENT 22 0.0002
800 FACE OEDEMA 4 0.0002
801 CARDIOVASCULAR DISORDER 6 0.0002
802 SEIZURE 27 0.0002
803 VISION BLURRED 32 0.0002
804 UNDERDOSE 17 0.0002
805 IRRITABILITY 14 0.0002
806 UNRESPONSIVE TO STIMULI 6 0.0002
807 MUSCULOSKELETAL DISCOMFORT 4 0.0002
808 DISCOMFORT 14 0.0002
809 OFF LABEL USE 200 0.0002
810 METASTASES TO LIVER 4 0.0002
811 MELAENA 5 0.0002
812 DISORIENTATION 9 0.0002
813 HYPOTENSION 45 0.0002
814 GOUT 4 0.0002
815 DISTURBANCE IN ATTENTION 12 0.0002
816 NAUSEA 176 0.0002
817 COUGH 62 0.0002
818 LEUKOCYTOSIS 4 0.0002
819 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
820 LUNG NEOPLASM MALIGNANT 9 0.0002
821 TINNITUS 10 0.0002
822 HYPERTENSION 46 0.0002
823 CARDIO-RESPIRATORY ARREST 9 0.0002
824 ROAD TRAFFIC ACCIDENT 9 0.0002
825 INFECTION 31 0.0002
826 PRODUCT USE IN UNAPPROVED INDICATION 53 0.0002
827 EYE DISORDER 7 0.0002
828 EYE PAIN 12 0.0002
829 RASH 92 0.0002
830 ANXIETY 60 0.0002
831 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
832 HAEMORRHAGE 22 0.0002
833 URINARY RETENTION 7 0.0002
834 MALAISE 90 0.0002
835 RASH PRURITIC 11 0.0002
836 ABASIA 5 0.0002
837 HAEMATOCRIT DECREASED 4 0.0002
838 WEIGHT INCREASED 45 0.0002
839 HYPOAESTHESIA 30 0.0002
840 HALLUCINATION 15 0.0002
841 SLEEP DISORDER 14 0.0002
842 ABDOMINAL PAIN LOWER 5 0.0002
843 INSOMNIA 52 0.0002
844 ERYTHEMA 40 0.0002
845 ANAPHYLACTIC SHOCK 5 0.0002
846 DYSPEPSIA 19 0.0002
847 HERPES ZOSTER 11 0.0002
848 DERMATITIS 4 0.0002
849 MUSCULOSKELETAL PAIN 10 0.0002
850 MOOD SWINGS 6 0.0002
851 DISEASE PROGRESSION 22 0.0002
852 PNEUMONIA 60 0.0002
853 DEEP VEIN THROMBOSIS 12 0.0002
854 AMNESIA 12 0.0002
855 VERTIGO 11 0.0002
856 MENTAL STATUS CHANGES 5 0.0002
857 PLASMA CELL MYELOMA 7 0.0002
858 HYPONATRAEMIA 10 0.0002
859 FATIGUE 138 0.0002
860 GASTRIC DISORDER 6 0.0002
861 HYPERSOMNIA 5 0.0002
862 PANCREATIC CARCINOMA 5 0.0002
863 BLOOD CHOLESTEROL INCREASED 8 0.0002
864 DYSSTASIA 5 0.0002
865 NO ADVERSE EVENT 31 0.0002
866 CARDIAC DISORDER 16 0.0002
867 SWELLING 16 0.0002
868 SURGERY 10 0.0002
869 POLLAKIURIA 7 0.0002
870 CHEST PAIN 31 0.0002
871 ABDOMINAL DISCOMFORT 28 0.0002
872 PAIN IN EXTREMITY 49 0.0002
873 LACRIMATION INCREASED 5 0.0002
874 INTERSTITIAL LUNG DISEASE 8 0.0002
875 ABDOMINAL PAIN UPPER 34 0.0002
876 AGITATION 12 0.0002
877 GAIT DISTURBANCE 31 0.0002
878 EXTRAPYRAMIDAL DISORDER 4 0.0002
879 SWOLLEN TONGUE 5 0.0002
880 SYNCOPE 16 0.0002
881 UNEVALUABLE EVENT 12 0.0002
882 TACHYCARDIA 14 0.0002
883 LETHARGY 9 0.0002
884 ADVERSE DRUG REACTION 14 0.0002
885 SKIN DISCOLOURATION 7 0.0002
886 ANHEDONIA 4 0.0002
887 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
888 DYSKINESIA 6 0.0001
889 OCULAR HYPERAEMIA 7 0.0001
890 MEMORY IMPAIRMENT 20 0.0001
891 DYSPNOEA 82 0.0001
892 HYPOGLYCAEMIA 7 0.0001
893 SOMNOLENCE 28 0.0001
894 ARTHRALGIA 57 0.0001
895 INTENTIONAL PRODUCT MISUSE 12 0.0001
896 PRURITUS 52 0.0001
897 PRODUCT USE ISSUE 25 0.0001
898 INTESTINAL OBSTRUCTION 5 0.0001
899 THERAPEUTIC RESPONSE DECREASED 8 0.0001
900 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
901 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
902 LIMB DISCOMFORT 4 0.0001
903 ARRHYTHMIA 6 0.0001
904 COVID-19 22 0.0001
905 OVERDOSE 27 0.0001
906 CARDIAC FAILURE CONGESTIVE 10 0.0001
907 HYPERSENSITIVITY 23 0.0001
908 PSORIATIC ARTHROPATHY 5 0.0001
909 CONVULSION 7 0.0001
910 PRODUCT SUBSTITUTION ISSUE 7 0.0001
911 PARAESTHESIA 19 0.0001
912 BACK PAIN 28 0.0001
913 GAIT INABILITY 4 0.0001
914 CHILLS 14 0.0001
915 HYPOACUSIS 5 0.0001
916 STOMATITIS 7 0.0001
917 ECZEMA 6 0.0001
918 SPEECH DISORDER 6 0.0001
919 FEELING HOT 7 0.0001
920 HEART RATE DECREASED 4 0.0001
921 BRADYCARDIA 6 0.0001
922 CARDIAC FAILURE 9 0.0001
923 THROMBOSIS 9 0.0001
924 URINARY TRACT INFECTION 19 0.0001
925 MOBILITY DECREASED 8 0.0001
926 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
927 LOSS OF CONSCIOUSNESS 14 0.0001
928 DIZZINESS 54 0.0001
929 INFLUENZA 12 0.0001
930 EYE SWELLING 4 0.0001
931 NECK PAIN 6 0.0001
932 EPISTAXIS 8 0.0001
933 BLISTER 6 0.0001
934 FLATULENCE 6 0.0001
935 VISUAL IMPAIRMENT 13 0.0001
936 CONTUSION 10 0.0001
937 FALL 34 0.0001
938 ARTHRITIS 8 0.0001
939 ABNORMAL BEHAVIOUR 4 0.0001
940 HEART RATE INCREASED 10 0.0001
941 BURNING SENSATION 7 0.0001
942 PAIN 61 0.0001
943 ILL-DEFINED DISORDER 6 0.0001
944 HOSPITALISATION 15 0.0001
945 PERIPHERAL SWELLING 15 0.0001
946 CONSTIPATION 20 0.0001
947 BLOOD PRESSURE DECREASED 6 0.0001
948 ARTHROPATHY 5 0.0001
949 COLITIS ULCERATIVE 4 0.0001
950 CHEST DISCOMFORT 9 0.0001
951 DRY MOUTH 7 0.0001
952 HYPERHIDROSIS 11 0.0001
953 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
954 MUSCLE SPASMS 15 0.0001
955 AGGRESSION 4 0.0001
956 MUSCULOSKELETAL STIFFNESS 7 0.0001
957 BLOOD PRESSURE INCREASED 12 0.0001
958 INTENTIONAL OVERDOSE 5 0.0001
959 NERVOUSNESS 4 0.0001
960 ALOPECIA 15 0.0001
961 OROPHARYNGEAL PAIN 7 0.0001
962 BREAST CANCER 7 0.0001
963 PROSTATE CANCER 6 0.0001
964 JOINT SWELLING 9 0.0001
965 COMPLETED SUICIDE 6 0.0001
966 ASTHMA 8 0.0001
967 DRUG WITHDRAWAL SYNDROME 6 0.0001
968 DRUG DOSE OMISSION 11 0.0001
969 ATRIAL FIBRILLATION 6 0.0001
970 INFLUENZA LIKE ILLNESS 5 0.0001
971 ILLNESS 6 0.0001
972 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
973 MIGRAINE 5 0.0001
974 FLUSHING 5 0.0000
975 SINUSITIS 5 0.0000
976 URTICARIA 8 0.0000
977 PSORIASIS 6 0.0000
978 PRODUCT QUALITY ISSUE 6 0.0000
979 EMOTIONAL DISTRESS 5 0.0000
980 INCORRECT DOSE ADMINISTERED 9 0.0000
981 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
982 FEELING ABNORMAL 9 0.0000
983 BLOOD GLUCOSE INCREASED 7 0.0000
984 PRODUCT DOSE OMISSION ISSUE 10 0.0000
985 NASOPHARYNGITIS 5 0.0000
986 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000